Abstract:Introduction Cardiac lymphomas are rare and can be fatal if not diagnosed and treated appropriately. They are commonly diffuse large B cell lymphomas (DLBCL) presenting with secondary cardiac involvement. Primary cardiac lymphomas are rarer with an incidence rate of 0.25%. Patients typically have heart failure symptoms, which can confound diagnosis with more common etiologies. Masses are often identified by imaging, but further modalities and tissue biopsy are required to identify the etiology before pursuing treatment. We discuss a rare case of a primary DLBCL arising from the interventricular septum. Case Presentation A 47-year-old woman with a PMH of DLBCL of the right groin in 2017 was in remission after chemotherapy. She presented with symptoms of chest pressure, dyspnea, palpitations, and dizziness. A CT angiogram was ordered to evaluate pulmonary embolism resulted with hypoenhancement of the right ventricle (RV). Echocardiography subsequently revealed a homogenous mass in the RV causing massive RV dilatation and hypokinesis, and compression of the LV (Fig. 1). Cardiac MRI demonstrated invasion of the mass into the interventricular septum and wall of the LV, making her a poor candidate for surgical resection. Biopsy of the mass by pathology identified it as DLBCL. The patient was started on rituximab, ifosfamide, carboplatin, and etoposide. Serial echocardiography was performed during treatment with the mass regressing to a third of its original size without cardiac perforation (Fig. 2). After clinical improvement, she was discharged and returned to her previous oncologists for continued treatment. Discussion Primary cardiac lymphomas are rare. Once diagnosed, the treatment includes aggressive chemotherapy or surgical resection. Masses arising from the structures of the heart have the potential to cause cardiac perforation and subsequent demise of the patient during regression. These patients can be successfully managed with multidisciplinary involvement and careful monitoring.

Oncologic emergencies in the patient with lymphoma

Common complications and emergencies associated with cancer and its therapy

Review of Hematological and Oncological Emergencies

Review of Hematology-Oncology Emergencies for Internal Medicine Residents

A narrative review of oncologic emergencies in patients with head and neck cancers: initial management and the role of radiation therapy

Abdominal Emergencies in Cancer Patients

Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment

Evaluating the Oncology-Related Education Needs of Emergency Nurses

Unveiling of Type B Lactic Acidosis From Systemic Lupus Erythematosus-Associated B-cell Lymphoma: A Fatal Oncology Emergency

Lymphedema and implications for oncology nursing practice

Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma

Why, When and How I Treat?

Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management

Emergency radiation therapy in modern-day practice: Now or never, or never again ?

Palliating hematologic oncologic emergencies with radiation in the age of targeted systemic therapies: three illustrative cases

Prevalence of and Risk Factors for Venous Thromboembolism in Patients with Lymphoma: A Meta-Analysis.

Cardiovascular mortality among patients with non‐Hodgkin lymphoma: Differences according to lymphoma subtype

Potentially fatal complications of new systemic anticancer therapies: pearls and pitfalls in their initial management

An Aggressive Form of Non-Hodgkin's Lymphoma with Pleural and Abdominal Chylous Effusions: A Case Report and Review of the Literature

Management Of A High-risk Rare Primary Cardiac Lymphoma

Early Recognition and Management of Side Effects Related to Systemic Anticancer Therapy for Advanced Breast Cancer